Cardlytics Capex To Revenue from 2010 to 2024
CDLX Stock | USD 9.40 0.63 7.18% |
Capex To Revenue | First Reported 2010-12-31 | Previous Quarter (0.04) | Current Value (0.04) | Quarterly Volatility 0.0231497 |
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 16.8 M, as well as many exotic indicators such as Price To Sales Ratio of 1.03, Dividend Yield of 0.0 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
Cardlytics | Capex To Revenue |
Latest Cardlytics' Capex To Revenue Growth Pattern
Below is the plot of the Capex To Revenue of Cardlytics over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Cardlytics' Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue | 10 Years Trend |
|
Capex To Revenue |
Timeline |
Cardlytics Capex To Revenue Regression Statistics
Arithmetic Mean | (0.06) | |
Coefficient Of Variation | (40.77) | |
Mean Deviation | 0.02 | |
Median | (0.05) | |
Standard Deviation | 0.02 | |
Sample Variance | 0.0005 | |
Range | 0.0685 | |
R-Value | 0.65 | |
Mean Square Error | 0.0003 | |
R-Squared | 0.43 | |
Significance | 0.01 | |
Slope | 0 | |
Total Sum of Squares | 0.01 |
Cardlytics Capex To Revenue History
About Cardlytics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cardlytics income statement, its balance sheet, and the statement of cash flows. Cardlytics investors use historical funamental indicators, such as Cardlytics's Capex To Revenue, to determine how well the company is positioned to perform in the future. Although Cardlytics investors may use each financial statement separately, they are all related. The changes in Cardlytics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cardlytics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cardlytics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Capex To Revenue | (0.04) | (0.04) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cardlytics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardlytics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardlytics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardlytics Stock:Check out the analysis of Cardlytics Correlation against competitors. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Cardlytics Stock analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.57) | Earnings Share (4.66) | Revenue Per Share 8.033 | Quarterly Revenue Growth 0.051 | Return On Assets (0.06) |
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.